Search

Search Constraints

You searched for: Author/Creator Howarth, Peter

Search Results

11. Clinical evaluation of type 2 disease status in a real‐world population of difficult to manage asthma using historic electronic healthcare records of blood eosinophil counts. Issue 6 (18th February 2021)

12. Oral corticosteroid-sparing effects of mepolizumab in severe eosinophilic asthma: evidence from randomized controlled trials and real-world studies. (August 2022)

14. Association of endopeptidases, involved in SARS‐CoV‐2 infection, with microbial aggravation in sputum of severe asthma. Issue 6 (25th January 2021)

15. Nontypeable Haemophilus influenzae infection of pulmonary macrophages drives neutrophilic inflammation in severe asthma. Issue 10 (30th May 2022)

17. Urinary metabotype of severe asthma evidences decreased carnitine metabolism independent of oral corticosteroid treatment in the U-BIOPRED study. Issue 6 (30th June 2022)

18. Vulnerability to acid reflux of the airway epithelium in severe asthma. Issue 2 (4th August 2022)

19. The effect of the COVID-19 pandemic on severe asthma care in Europe: will care change for good?. Issue 2 (16th May 2022)